Schlagwörter
Oncology
12
Hematology
10
/dk/atira/pure/keywords/researchprograms/AFL000800/EMCNIHES056302
6
/dk/atira/pure/keywords/researchprograms/AFL001000/EMCMM038608
6
name=EMC MM-03-86-08
6
name=EMC NIHES-05-63-02 Quality
6
Environmental and Occupational Health
4
Health Policy
4
Public Health
4
/dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01
2
/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
2
AGE
2
Cancer Research
2
DABRAFENIB
2
DOUBLE-BLIND
2
IMMUNOTHERAPY
2
IPILIMUMAB
2
Immune checkpoint inhibitors
2
MULTICENTER
2
Metastatic melanoma
2
NIVOLUMAB
2
Older patients
2
Outcome
2
STAGE-III
2
Safety
2
Targeted therapy
2
VEMURAFENIB
2
braf
2
combined nivolumab
2
dabrafenib
2
double-blind
2
dutch melanoma treatment registry
2
ipilimumab
2
metastatic melanoma
2
multicenter
2
name=EMC OR-01
2
name=SDG 3 - Good Health and Well-being
2
open-label
2
phase-3
2
surgery
2
survival
2
systemic therapy
2